Physician profile
Allison C Carmichael
NPI 1942553391
$1,430.95
in general payments reported to CMS, 2019-2025
10 companies · $437 in 2025
The $437 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $88.00 · 2022: $201 · 2023: $127 · 2024: $164 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $431.29 | 2022-2025 | Ozempic, Rybelsus |
| Beta Bionics, INC. | $376.11 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Mannkind Corporation | $178.20 | 2019 | |
| Companion Medical, INC. | $125.67 | 2019 | |
| Ascendis Pharma Endocrinology INC | $121.82 | 2025 | Yorvipath |
| Amgen INC. | $88.00 | 2020 | |
| Antares Pharma, INC. | $39.47 | 2019 | |
| Radius Health, INC. | $36.03 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.22 | 2019 | |
| Abbott Laboratories | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.